Who Exports Daunorubicin from India — 113 Suppliers Behind a $692.3K Market
India's daunorubicin export market is supplied by 113 active exporters who collectively shipped $692.3K across 400 shipments. BIOZENTA LIFESCIENCE PRIVATE LIMITED leads with a 12.6% market share, followed by ZANDRA LIFE SCIENCES PRIVATE LIMITED and NAPROD LIFE SCIENCES PRIVATE LIMITED. The top 5 suppliers together control 44.1% of total export value, reflecting a moderately competitive market structure.
Top Daunorubicin Exporters from India — Ranked by Export Value
BIOZENTA LIFESCIENCE PRIVATE LIMITED is the leading daunorubicin exporter from India, holding a 12.6% share of the $692.3K market across 400 shipments from 113 exporters. The top 5 suppliers — BIOZENTA LIFESCIENCE PRIVATE LIMITED, ZANDRA LIFE SCIENCES PRIVATE LIMITED, NAPROD LIFE SCIENCES PRIVATE LIMITED, UNITED BIOTECH PRIVATE LIMITED, 3S CORPORATION — collectively control 44.1% of total export value, indicating a competitive market. Individual shares are: BIOZENTA LIFESCIENCE PRIVATE LIMITED (12.6%), ZANDRA LIFE SCIENCES PRIVATE LIMITED (11.7%), NAPROD LIFE SCIENCES PRIVATE LIMITED (8.3%), UNITED BIOTECH PRIVATE LIMITED (6.1%), 3S CORPORATION (5.4%).
Top Daunorubicin Exporters from India
Ranked by export value · 113 active suppliers · Indian Customs (DGFT) data
| # | Supplier & Formulations | Value | Ctry. | Share |
|---|---|---|---|---|
| 1 | BIOZENTA LIFESCIENCE PRIVATE LIMITED DAUNORUBICIN CITRATE LIPOSOME INJECTIONDAUNORUBICIN LIPOSOMAL INJECTION 50 MG/VIALAL DAUNO DAUNORUBICIN HYDROCHLORIDE FOR | $87.0K | 2 | 12.6% |
| 2 | ZANDRA LIFE SCIENCES PRIVATE LIMITED DAUNORUBICIN HCL FOR INJECTION USP 20 MG/VIALDUNOLDN 20 (DAUNORUBICINE HYDROCHLORIDEDAUNORUBICIN 20MG NO.1,BATCH NUMBER :OL2 | $81.0K | 1 | 11.7% |
| 3 | NAPROD LIFE SCIENCES PRIVATE LIMITED DAUNORUBICIN CITRATE LIPOSOME INJECTIONDAUNORUBICIN LIPOSOMAL INJECTION 50 MG/VIALAL DAUNO DAUNORUBICIN HYDROCHLORIDE FOR | $57.6K | 1 | 8.3% |
| 4 | UNITED BIOTECH PRIVATE LIMITED DAUNORUBICIN HYDROCHLORIDE FOR INJECTIONUSP 20MG DAUNOPLUSDAUNORUBITEC 20DAUNOTEC INJ | $42.4K | 7 | 6.1% |
| 5 | 3S CORPORATION COMBIPACK OF DAUNORUBICIN FOR INJECTIONDAUNEON 20 MG | $37.5K | 4 | 5.4% |
| 6 | MEDICINE HOUSE DAUNEON 20 MG | $26.1K | 1 | 3.8% |
| 7 | VHB MEDI SCIENCES LIMITED DAUNORUBICIN HYDROCHLORIDE FOR INJECTIONUSP 20MG DAUNOPLUSDAUNORUBITEC 20DAUNORUBICIN HYDROCHLORIDE FOR INJECTION | $17.5K | 4 | 2.5% |
| 8 | NEON LABORATORIES LIMITED DAUNORUBICIN HYDROCHLORIDE FOR INJECTIONDAUNORUBICIN HYDROCHLORIDE FOR INJECTIONUSP 20 MG DAUNOPLUSDAUNEON 20MG INJ | $10.2K | 3 | 1.5% |
| 9 | SARA INTERNATIONAL | $9.3K | 1 | 1.3% |
| 10 | TRIKAYA GLOBAL DAUNORUBICIN HYDROCHLORIDE FOR INJECTIONDAUNORUBICIN HYDROCHLORIDE FOR INJECTIONUSP 20 MG DAUNOPLUSDAUNEON 20MG INJ | $8.2K | 2 | 1.2% |
Related Analysis
Supplier Certification & Compliance Matrix
FDA, WHO-GMP, and EU GMP status for top Daunorubicin exporters
| Supplier | US FDA | WHO-GMP | EU GMP | ANDAs | Notes |
|---|---|---|---|---|---|
| BIOZENTA LIFESCIENCE PRIVATE LIMITED | Not Listed | Yes, as of September | No | Not verified | WHO-GMP certified for cytotoxic drugs and general category products. |
| NAPROD LIFE SCIENCES PRIVATE LIMITED | Not Listed | Yes, as of January 2 | Yes | Not verified | EU-GMP certified by Hungary's National Institute of Pharmacy and Nutrition. (dav |
| UNITED BIOTECH PRIVATE LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certified; specific certification date not found. |
| VHB MEDI SCIENCES LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certified; specific certification date not found. |
| NEON LABORATORIES LIMITED | Not Listed | Yes | No | Not verified | WHO-GMP certified; specific certification date not found. |
TransData Nexus reviewed the regulatory standing of 5 leading Daunorubicin exporters from India. 0 hold US FDA facility approvals, 5 maintain WHO-GMP certification, and 1 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.
Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.
TransData Nexus Research · Mar 2026
Manufacturing Hub Analysis — Vendor Proximity
India's pharmaceutical clusters relevant to Daunorubicin sourcing
1Hyderabad — Bulk Drug Capital
Hyderabad, often referred to as the "Bulk Drug Capital of India," is a pivotal hub for the production of Active Pharmaceutical Ingredients (APIs). The city hosts over 800 pharmaceutical companies, including major players like Dr. Reddy’s Laboratories, Aurobindo Pharma, and Divi’s Laboratories. The presence of Genome Valley, India's first biotech cluster, underscores Hyderabad's commitment to pharmaceutical innovation and research. This robust infrastructure makes Hyderabad a prime location for sourcing high-quality APIs, including Daunorubicin.
2Ahmedabad-Vadodara — Formulations Hub
The Ahmedabad-Vadodara corridor in Gujarat is renowned for its expertise in pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production, with a strong presence of companies like Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals. The region's well-established infrastructure and regulatory compliance make it a strategic choice for sourcing finished formulations of Daunorubicin.
3Mumbai-Thane-Raigad — Export Gateway
The Mumbai-Thane-Raigad belt in Maharashtra serves as a critical export gateway for pharmaceutical products. With 929 pharmaceutical units, Maharashtra's strategic coastal location facilitates efficient international shipping. This region's extensive manufacturing capabilities and export-oriented infrastructure make it a viable option for sourcing Daunorubicin intended for global markets.
4Baddi-Nalagarh — Tax Incentive Zone
Baddi, located in Himachal Pradesh, is recognized as Asia's largest pharmaceutical hub, housing over 1,000 manufacturing units. The region's growth has been significantly influenced by favorable government policies, including tax incentives, which have attracted numerous pharmaceutical companies. Baddi's prominence in the industry makes it a noteworthy area for sourcing pharmaceutical products.
5Sourcing Recommendations
- Diversify Supplier Base: Given that the top five exporters account for 44.1% of Daunorubicin shipments, it's prudent to engage with multiple suppliers across different clusters to mitigate supply chain risks.
- Evaluate Supplier Capabilities: Assess the manufacturing capabilities and regulatory compliance of suppliers in Hyderabad for APIs and in Ahmedabad-Vadodara for formulations to ensure product quality.
- Leverage Export Infrastructure: Utilize the export facilities in the Mumbai-Thane-Raigad region to streamline international distribution of Daunorubicin.
- Consider Cost Advantages: Explore sourcing options in Baddi-Nalagarh to benefit from potential cost savings due to tax incentives and a competitive manufacturing environment.
By strategically engaging with suppliers across these key pharmaceutical clusters, TransData Nexus can optimize its sourcing strategy for Daunorubicin, ensuring a robust and efficient supply chain.
Recent M&A, Collaborations & Capacity Expansions
Industry developments among top Daunorubicin exporters from India
Biozenta Lifescience Private Limited — Biozenta appoints new directors to strengthen leadership team
In January 2024, Biozenta Lifescience Private Limited appointed new directors, including Babita Saini, Abhishek Jain, and Subodh Saini, to enhance its leadership structure. IMPACT: These leadership changes are expected to bolster Biozenta's strategic direction, potentially influencing its Daunorubicin export operations.
Impact: These leadership changes are expected to bolster Biozenta's strategic direction, potentially influencing its Daunorubicin export operations.
Zandra Life Sciences Private Limited — Zandra introduces new biological products to enhance therapeutic offerings
In December 2025, Zandra Life Sciences expanded its product portfolio by introducing new biological products, including Rituximab and Filgrastim, aiming to diversify its therapeutic offerings. IMPACT: This expansion may lead to increased production capabilities, potentially affecting Daunorubicin export volumes.
Impact: This expansion may lead to increased production capabilities, potentially affecting Daunorubicin export volumes.
Biozenta Lifescience Private Limited — Biozenta secures PIC/S approval for manufacturing facility
In February 2026, Biozenta Lifescience's manufacturing facility received approval from the Pharmaceutical Inspection Co-operation Scheme (PIC/S), enhancing its compliance with international quality standards. IMPACT: This approval is likely to boost Biozenta's credibility in international markets, potentially increasing Daunorubicin exports.
Impact: This approval is likely to boost Biozenta's credibility in international markets, potentially increasing Daunorubicin exports.
Common Questions — Daunorubicin Suppliers from India
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which daunorubicin supplier from India is the most reliable for bulk orders?
Based on shipment frequency and export consistency, BIOZENTA LIFESCIENCE PRIVATE LIMITED leads with 6 recorded shipments worth $87.0K. ZANDRA LIFE SCIENCES PRIVATE LIMITED (6 shipments) and NAPROD LIFE SCIENCES PRIVATE LIMITED (4 shipments) are also established high-volume exporters.
Q How many daunorubicin manufacturers are there in India?
India has 113 active daunorubicin exporters with a combined export market of $692.3K across 400 shipments to 66 countries. The top 5 suppliers hold 44.1% of total export value.
Q What certifications should I verify?
Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).
Q What is the typical price range for daunorubicin from India?
Average FOB unit price: $6.86 per unit, ranging from $0.06 to $368.72. Average shipment value: $1.7K.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Supplier Ranking: 113 verified Indian exporters of Daunorubicin ranked by capped export value from DGFT shipping bill records.
- 2.Export Value Analysis: Total export value aggregated from 400 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Market Concentration: Supplier market share and geographic reach analyzed across 66 destination countries.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
400 Verified Shipments
113 exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists